Cassini, developer of corneal diagnostic solutions, has successfully closed a series A financing round with venture capital fund Innovation Industries.
Funding
The raised funds will be used to accelerate the development and commercialisation of a diagnostic platform for premium refractive cataract surgery procedure, Cassini. This platform provides diagnostic analysis of the entire cornea, including the posterior surface.
Jeroen Cammeraat, CEO commented: “Innovation Industries shares our long-term vision of continuous innovation with the goal of delivering the best possible refractive outcomes to patients, while at the same time improving operational efficiencies and providing to surgeons and industry partners an indispensable technology platform for seamless integration of the clinic and surgical suite.”
“We are very excited about our investment in Cassini,” revealed Chris Sonnenberg, general partner at Innovation Industries. “Cassini has built an impressive global customer base and has started to generate very compelling clinical data. We strongly support the vision of the leadership team to accelerate R&D and clinical study efforts to bring Cassini to the next performance level and expand strategic partnerships to other key players in the industry.”
Twelve studies were presented at last year’s Congress of the European Society of Cataract and Refractive Surgeons in Lisbon, Portugal, demonstrating the clinical efficacy of the Cassini platform.